Rocket


News + Filings
Transactions
Holdings





Machado Patrick

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
10/04/2023ACELYRIN, Inc. Other (acquisition)Common Stock14.7k$0.00$0See footnote10/04/2023
06/15/2023Arcus Biosciences, Inc.RCUSGrantStock Option (Right to Buy)19.5k$19.60$382.2k 06/15/2023
06/15/2023Arcus Biosciences, Inc.RCUSGrantCommon Stock6.8k$0.00$0 06/15/2023
06/09/2023CHIMERIX INCCMRXGrantStock Option (Right to Buy)60k$1.39$83.4k 06/09/2023
06/02/2023Xenon Pharmaceuticals Inc.XENEGrantStock Option (Right to Buy)18.5k$38.96$719.8k 06/02/2023
05/09/2023ACELYRIN, Inc. Other (acquisition)Director Stock Option (right to buy)23.2k$18.00$418.4k 05/09/2023
05/09/2023ACELYRIN, Inc. Other (acquisition)Director Stock Option (right to buy)86.2k$5.88$506.6k 05/09/2023
05/09/2023ACELYRIN, Inc. Other (disposition)Director Stock Option (right to buy)86.2k$5.88$506.6k 05/09/2023
05/09/2023ACELYRIN, Inc. Other (acquisition)Director Stock Option (right to buy)40.6k$0.77$31.2k 05/09/2023
05/09/2023ACELYRIN, Inc. Other (disposition)Director Stock Option (right to buy)40.6k$0.77$31.2k 05/09/2023
05/09/2023ACELYRIN, Inc. Other (disposition)Director Stock Option (right to buy)23.2k$18.00$418.4k 05/09/2023
05/09/2023ACELYRIN, Inc. Other (acquisition)Director Stock Option (right to buy)28.7k$5.88$168.5k 05/09/2023
05/09/2023ACELYRIN, Inc. Other (disposition)Director Stock Option (right to buy)28.7k$5.88$168.5k 05/09/2023
05/04/2023ACELYRIN, Inc. GrantDirector Stock Option (right to buy)23.2k$18.00$418.4k 05/04/2023
08/17/2022Turning Point Therapeutics, Inc.TPTXDispositionStock Option (right to buy)30k$29.56$886.8k 08/17/2022
08/17/2022Turning Point Therapeutics, Inc.TPTXDispositionStock Option (right to buy)8.5k$65.39$555.8k 08/17/2022
08/17/2022Turning Point Therapeutics, Inc.TPTXDispositionStock Option (right to buy)8.5k$65.64$557.9k 08/17/2022
06/28/2022Xenon Pharmaceuticals Inc.XENEGrantStock Option (Right to Buy)18k$30.11$542k 06/28/2022
06/23/2022CHIMERIX INCCMRXGrantStock Option (Right to Buy)50k$1.82$91k 06/23/2022
06/14/2022Arcus Biosciences, Inc.RCUSGrantCommon Stock4.1k$0.00$0 06/14/2022
06/14/2022Arcus Biosciences, Inc.RCUSGrantStock Option (Right to Buy)16.8k$20.62$346.4k 06/14/2022
06/10/2022Adverum Biotechnologies, Inc.ADVMGrantStock Option (Right to Buy)12.5k$0.99$12.4k 06/10/2022
06/10/2022Adverum Biotechnologies, Inc.ADVMGrantStock Option (Right to Buy)40k$0.99$39.6k 06/10/2022
06/23/2021CHIMERIX INCCMRXGrantStock Option (Right to Buy)35k$7.84$274.4k 06/23/2021
06/03/2021Arcus Biosciences, Inc.RCUSGrantStock Option (Right to Buy)14.1k$24.79$349.5k 06/03/2021
06/03/2021Arcus Biosciences, Inc.RCUSGrantCommon Stock3k$0.00$0 06/03/2021
06/03/2021Xenon Pharmaceuticals Inc.XENEGrantStock Option (Right to Buy)10k$18.56$185.6k 06/03/2021
06/02/2021Turning Point Therapeutics, Inc.TPTXGrantStock Option (right to buy)8.5k$65.64$557.9k 06/02/2021
05/12/2021Adverum Biotechnologies, Inc.ADVMGrantStock Option (Right to Buy)40k$3.70$148k 05/12/2021
05/12/2021Adverum Biotechnologies, Inc.ADVMGrantStock Option (Right to Buy)12.5k$3.70$46.2k 05/12/2021
03/24/2021Adverum Biotechnologies, Inc.ADVMPurchaseCommon Stock10k$9.92$99.2k 03/24/2021
01/15/2021Adverum Biotechnologies, Inc.ADVMPurchaseCommon Stock10k$11.52$115.2k 01/15/2021
11/05/2020Xenon Pharmaceuticals Inc.XENEGrantStock Option (Right to Buy)20k$11.85$237k 11/05/2020
09/28/2020Principia Biopharma Inc.PRNBDispositionDirector Stock Option (right to buy)10.2k$31.77$325.3k 09/28/2020
09/28/2020Principia Biopharma Inc.PRNBDispositionDirector Stock Option (right to buy)20.5k$31.77$650.5k 09/28/2020
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy